Saunatica
Tirzepatide

WEIGHT LOSS — GLP-1

Tirzepatide

Dual-action GLP-1 and GIP therapy — two clinically studied mechanisms working together to support healthy, sustainable weight management.

Select your plan

1 month plan · total

$239

$239/mo

Continue to checkout — $239
  1. 1)Secure checkout
  2. 2)Complete your health intake in your patient portal
  3. 3)A licensed provider reviews — labs may be required
  4. 4)If prescribed, shipped to your door

An independent licensed provider decides what care is appropriate. Your secure patient portal is the next step.

support@saunaticarx.com · Verify LegitScript certification

Compounded medication, not FDA-approved. Prescription requires provider evaluation.

Store in refrigerator between doses.

About

What is Tirzepatide?

Dual GLP-1 and GIP receptor therapy for weight management. Compounded, not FDA-approved.

Tirzepatide activates two gut hormone receptors instead of one. Alongside the appetite and satiety effects of GLP-1, the GIP pathway supports how your body handles glucose and stores fat — which is why many patients see stronger results than with a single-mechanism therapy.

Your plan is a flat monthly rate regardless of the dose adjustments your provider makes as you titrate.

Every plan includes

Care, supplies and support

  • Ongoing provider care and support
  • Syringes and alcohol pads kit
  • Platform access and educational content

Targets both GLP-1 and GIP receptors

  • $239/mo
  • Dual GLP-1 and GIP mechanism
  • Ongoing provider care included
  • Flat price as your dose titrates
Continue to checkout — $239
  1. 1)Secure checkout
  2. 2)Complete your health intake in your patient portal
  3. 3)A licensed provider reviews — labs may be required
  4. 4)If prescribed, shipped to your door

An independent licensed provider decides what care is appropriate. Your secure patient portal is the next step.

support@saunaticarx.com · Verify LegitScript certification

Be informed

Possible side effects

Every prescription has trade-offs. Your provider reviews these with you before approving treatment.

  • Nausea
  • Vomiting
  • Diarrhea
  • Hypoglycemia risk
  • Thyroid tumor risk (rodent studies)

Your questions, answered

Frequently asked questions

How is Tirzepatide different from Semaglutide?

Semaglutide acts on the GLP-1 receptor. Tirzepatide acts on GLP-1 and GIP receptors, a dual mechanism associated with greater average weight loss in clinical studies.

Does the price change as my dose increases?

No. Your plan is a flat rate for the term you select, regardless of dose adjustments made by your provider.

How is it shipped?

Discreetly, in unbranded packaging, from an accredited pharmacy. Most orders ship within 24–48 hours of provider approval.

Can I cancel?

You can cancel for a full refund any time before your order ships. Once it ships, all sales are final, including multi-month plans.

Also in Weight Loss — GLP-1

Metformin XR 500

Metformin XR 500

A caloric restriction mimetic with decades of safety data, used for metabolic health and longevity.

Learn more →
Continue to checkout — $65
  1. 1)Secure checkout
  2. 2)Complete your health intake in your patient portal
  3. 3)A licensed provider reviews — labs may be required
  4. 4)If prescribed, shipped to your door

An independent licensed provider decides what care is appropriate. Your secure patient portal is the next step.

support@saunaticarx.com · Verify LegitScript certification

Important information

Actual product appearance and labeling of the medication you receive will differ from website images.

This is a compounded medication and is not FDA-approved. Its safety and effectiveness have not been verified by the FDA.

Prescription products require an online consultation with a licensed healthcare provider who will determine whether a prescription is appropriate.

Payment does not guarantee that a prescription will be issued or that medication will be dispensed. Any prescription is based solely on the professional judgment of the licensed provider.

Medications are only issued when clinically appropriate after provider evaluation.